Medications for Schizophrenia

Schizophrenia is a serious chronic mental health disorder characterized by disruptions in thought, perception, emotions, and behavior that can profoundly affect a person's ability to function in daily life. The condition involves complex interactions between genetic vulnerability, changes in brain structure and dopamine or glutamate signaling, and environmental stressors such as prenatal viral exposure or cannabis use during adolescence. Schizophrenia affects approximately 1% of the population worldwide and most often first appears in the late teens to mid-30s, tending to emerge earlier in men than women. Symptoms are divided into positive symptoms (hallucinations, delusions, and disorganized thinking) and negative symptoms (flat affect, social withdrawal, reduced motivation, and reduced ability to experience pleasure). Cognitive symptoms such as problems with memory and attention are also common and can interfere with everyday functioning.

Without treatment, schizophrenia can lead to severe functional impairment, social isolation, and significantly shorter life expectancy — largely due to cardiovascular disease, metabolic effects, and suicide risk. Antipsychotic medications are the cornerstone of treatment and work primarily by blocking dopamine D2 receptors to reduce positive symptoms. First-generation (typical) antipsychotics such as haloperidol and chlorpromazine were the original class, while second-generation (atypical) antipsychotics such as risperidone, olanzapine, clozapine, and quetiapine are now more commonly used and offer a broader symptom profile. Long-acting injectable (LAI) formulations improve medication adherence, which is a major challenge in schizophrenia management. The medications listed below are among the most commonly prescribed for managing schizophrenia.